← Back to front page
Europe · Exchanges & live quotes · Finanzen.net

EQS-News: Immunic to Host Virtual Progressive Multiple Sclerosis R&D Day on November 5, 2026

Published by Finanzen.net · Germany 10 h ago

NEW YORK, October 29, 2026 – Immunic, Inc. (Nasdaq: IMUX), a late-stage biotechnology company pioneering the development of novel oral therapies for neurologic diseases, today…

Read the full article on Finanzen.net Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.finanzen.net)

Also worth reading